Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcus Biosciences (RCUS) Shares Issued (2018 - 2025)

Arcus Biosciences has reported Shares Issued over the past 8 years, most recently at $279.0 million for Q4 2025.

  • Quarterly results put Shares Issued at $279.0 million for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $429.0 million (up 88.16% YoY), and the annual figure for FY2025 was $429.0 million, up 88.16%.
  • Shares Issued for Q4 2025 was $279.0 million at Arcus Biosciences, up from $8.0 million in the prior quarter.
  • Over the last five years, Shares Issued for RCUS hit a ceiling of $279.0 million in Q4 2025 and a floor of -$14.0 million in Q3 2022.
  • Median Shares Issued over the past 5 years was $8.0 million (2025), compared with a mean of $69.4 million.
  • Biggest five-year swings in Shares Issued: crashed 113.59% in 2021 and later surged 22700.0% in 2024.
  • Arcus Biosciences' Shares Issued stood at -$235000.0 in 2021, then tumbled by 5857.45% to -$14.0 million in 2022, then skyrocketed by 135.71% to $5.0 million in 2023, then soared by 4460.0% to $228.0 million in 2024, then rose by 22.37% to $279.0 million in 2025.
  • The last three reported values for Shares Issued were $279.0 million (Q4 2025), $8.0 million (Q3 2025), and $142.0 million (Q1 2025) per Business Quant data.